Midnight Sun GLP-3R (Retatrutide) – Triple Agonist Metabolic Support
Midnight Sun GLP-3R is a high-purity synthetic peptide featuring Retatrutide, a first-in-class triple agonist designed for advanced research and laboratory applications focused on profound metabolic regulation and multi-pathway endocrine signaling.
 
Retatrutide is a specialized 39-amino acid peptide researched for its unique "tri-agonist" mechanism. It is studied for its ability to simultaneously activate three critical incretin and metabolic receptors: Glucagon-like peptide-1 (GLP-1), Glucose-dependent insulinotropic polypeptide (GIP), and the Glucagon receptor (GCGR). This triple-action approach is extensively researched for its potent synergistic effects on energy expenditure, hepatic lipid metabolism, and glucose-dependent insulin secretion.
 
This advanced formulation is commonly utilized in research settings exploring the modulation of metabolic rate, the reduction of hepatic fat content, and the complex physiological pathways involved in systemic energy balance.
 
Triple Agonist Action: Targeted for research into simultaneous GLP-1, GIP, and Glucagon receptor signaling.
Metabolic Synergy: Studied for its role in enhancing thermogenesis and optimizing lipid metabolism.
Advanced Bioavailability: Engineered to maintain high structural stability for consistent experimental observation.
Precision Research Grade: Manufactured to rigorous standards for reproducible and high-fidelity laboratory results.
 
For research purposes only. Not for human or animal use.
 
Keep in a cool, dry place. For long-term preservation of bioactive signaling properties, storage at -20°C or -80°C is recommended. Once reconstituted, follow specific laboratory protocols for refrigerated storage and immediate use to prevent peptide degradation.
 
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.